Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
Magliano DJ, Chen L, Carstensen B, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(21):00327-2
Leggi
Effect of dapagliflozin on hematocrit in patients with type 2 diabetes at high cardiovascular risk: observations from DECLARE-TIMI 58
Kolkailah AA, Wiviott SD, Raz I, et al.
Diabetes Care. 2022;dc211668
Leggi
Changes in the prevalence of symptoms of depression, loneliness, and insomnia in U.S. older adults with type 2 diabetes during the COVID-19 pandemic: the Look AHEAD study
Chao AM, Wadden TA, Clark JM, et al.
Diabetes Care. 2022;45(1):74-82.
Leggi
Does COVID-19 predispose patients to type 1 diabetes mellitus?
Ata A, Jalilova A, Kırkgöz T, et al.
Clin Pediatr Endocrinol. 2022;31(1):33-37.
Leggi
The type 2 diabetes ‘modern preventable pandemic’ and replicable lessons from the COVID-19 crisis
Singer ME, Dorrance KA, Oxenreiter MM, et al.
Prev Med Rep. 2022;25:101636
Leggi
Continuous glucose monitoring in the hospital: an update in the era of COVID-19
Gothong C, Singh LG, Satyarengga M, Spanakis EK.
Curr Opin Endocrinol Diabetes Obes. 2022;29(1):1-9.
Leggi
Metabolic, structural and biochemical changes in diabetes and the development of heart failure
Ho KL, Karwi QG, Lopaschuk GD, et al.
Diabetologia. Pub. online 7 Jan 2022.
Leggi
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
Herder C, Roden M
Diabetologia. Pub. online 4 Jan 2022.
Leggi
30-year cardiovascular disease in type 1 diabetes: risk and risk factors differ by long-term patterns of glycemic control
Miller RG, Orchard TJ, Costacou T
Diabetes Care. 2022;45(1):142-150.
Leggi
Do gene–environment interactions have implications for the precision prevention of type 2 diabetes?
Sørensen TIA, Metz S, Kilpeläinen TO
Diabetologia. Pub. online 7 Jan 2022.
Leggi